JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, J.-B.
Right arrow Articles by Pappano, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, J.-B.
Right arrow Articles by Pappano, A. J.

Vol. 301, Issue 2, 501-506, May 2002


On the Role of Phosphatase in Regulation of Cardiac L-Type Calcium Current by Cyclic GMP

Jian-Bing Shen and Achilles J. Pappano

Department of Pharmacology, University of Connecticut Health Center, Farmington, Connecticut

    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Does cGMP, via protein kinase G, inhibit cAMP-stimulated Ca2+ current (ICa(L)) in mammalian ventricular myocytes by phosphorylating the calcium channel at a site different from that acted on by cAMP or by dephosphorylating the calcium channel through phosphatase(s)? We tested these possibilities in guinea pig ventricular myocytes superfused with Tyrode's solution (35°C) and dialyzed with adenosine 5'-O-(3-thiotriphosphate) ([ATPgamma S]pip). ATPgamma S is a kinase substrate but thiophosphorylated proteins are not phosphatase substrates. With 5 mM [ATPgamma S]pip, ICa(L) increased gradually over 20 to 25 min and then rapidly in the presence of 3-isobutyl-1-methylxanthine. 8-Bromo-cGMP (8-Br-cGMP; 1 mM) did not inhibit ICa(L) significantly (-3 ± 11.8%, n = 21) in contrast to results with ATP dialysis (Imai et al., 2001). Similar results were obtained with 0.1 mM carbachol (CCh). ICa(L) increased after longer dialysis (>= 40 min) with ATPgamma S; again, 8-Br-cGMP had no effect. Also, isoproterenol (ISO) did not stimulate and CCh, alone or in the presence of ISO, did not inhibit ICa(L). Block of CCh effect by ATPgamma S, although consistent with cGMP action in muscarinic inhibition, could be explained by guanosine 5'-O-(3-thiotriphosphate) (GTPgamma S) formation from ATPgamma S via nucleoside diphosphate kinase. GTPgamma S uncouples muscarinic and beta -adrenoceptors from intracellular effectors. Failure of 8-Br-cGMP to reduce ICa(L) irreversibly excludes calcium channel phosphorylation as an inhibitory mechanism. We propose that cGMP inhibits ICa(L) by activating phosphatase(s) in guinea pig ventricular myocytes.

    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Extrinsic regulation of heart function usually involves opposing actions by the autonomic nervous system. The yin-yang hypothesis placed the postjunctional actions in the context of intracellular messengers, cAMP and cGMP, and their respective protein kinases having opposite effects on cellular processes (Watanabe and Besch, 1975). One target, the L-type calcium channel, has received considerable attention because the cAMP-activated protein kinase (PKA) increases current (ICa(L)) through the channel whereas the cGMP-activated kinase (PKG) decreases it (reviewed in McDonald et al., 1994).

In mammalian ventricle, cGMP-inhibited phosphodiesterase (PDE) and PKG appear to be the principal effectors of cGMP with the former causing ICa(L) to increase as it allows cAMP to accumulate (Ono and Trautwein, 1991; Shirayama and Pappano, 1996). Activation of PKG, in the presence of elevated cAMP, inhibits the L-type calcium current but the proposed mechanisms differ. In rat ventricular myocytes, inhibition of ICa(L) by cGMP was ascribed to phosphorylation by PKG of the L-type calcium channel or an associated regulatory protein (Méry et al., 1991; Sumii and Sperelakis, 1995). When the alpha 1c subunit of the cardiac calcium channel is expressed in oocytes, 8-bromo-cGMP (8-Br-cGMP) inhibited basal current (Jiang et al., 2000). The PKG inhibitor KT5823 or replacement of serine by alanine at a consensus site (S533A) for PKG-dependent phosphorylation prevented inhibition by cGMP. In the alpha 1c component of the L-type channel, PKA phosphorylates a serine residue 1928 (Gao et al., 1997). Thus, antagonistic modulation of ICa(L) by cyclic nucleotides could be referable to phosphorylation of different regulatory sites on the alpha 1c subunit.

Activation of a phosphatase was excluded as a mechanism for inhibition by cGMP/PKG (Méry et al., 1991; Sumii and Sperelakis, 1995). This conclusion is at odds with the observation that acetylcholine (ACh), which increases cGMP, opposed PKA-dependent phosphorylation of proteins in guinea pig ventricular myocytes (Gupta et al., 1994). This was attributed to activation of protein phosphatase (PP). Okadaic acid, an inhibitor of PP, prevented dephosphorylation of proteins (Gupta et al., 1994) and inhibition of isoproterenol (ISO)-stimulated ICa(L) by ACh (Herzig et al., 1995). The phosphatase hypothesis was strengthened by evidence that inhibition of ICa(L) by carbachol (CCh) or 8-Br-cGMP was antagonized by dialysis with 300 nM okadaic acid (Sakai et al., 1999). As such, the results resemble those seen in GH4C1 cells where atrial natriuretic peptide increased a maxi-K channel current by activating a phosphatase through a cGMP/PKG pathway (White et al., 1993). Okadaic acid prevented maxi-K current stimulation by atrial natriuretic peptide. When Ba2+ current through alpha 1c subunits expressed in human embryonic kidney cells is elevated by forskolin-induced activation of adenylyl cyclase, phosphatase inhibition by okadaic acid potentiates this current and the phosphorylation of serine 1928 (Gao et al., 1997).

We evaluated the phosphatase activation hypothesis for cGMP action on ICa(L). Our experiments were done with ATPgamma S replacing ATP in the pipette solution [ATPgamma S]pip; 8-Br-cGMP was used to activate PKG. ATPgamma S is a kinase substrate; the thiophosphorylated substrate resists phosphatase action (Yount, 1975). With 3 mM [ATPgamma S]pip, ISO increased ICa(L) more than with ATP and the stimulant effect persisted when ISO was removed (Kameyama et al., 1985; Sipido et al., 1995). PKA and PKG phosphorylate the L-type calcium channel at different sites. With ATPgamma S present, we assume that if the effect of thiophosphorylation by PKA on ICa(L) cannot be reversed by activation of PKG, the antagonistic interaction in ATP occurs by dephosphorylation of the site phosphorylated by cAMP/PKA. On the other hand, if cGMP can oppose the effect of cAMP on ICa(L) in the presence of ATPgamma S, the antagonism most likely occurs by thiophosphorylation of a different regulatory site on the alpha 1c subunit.

    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Ventricular Myocyte Isolation. Single ventricular myocytes were isolated from the hearts of guinea pigs (250-450 g) anesthetized with sodium pentobarbital (30 mg/kg, intraperitoneally) and anticoagulated with heparin (1000 IU, i.p.). The heart was perfused according to the Langendorff technique with modified Tyrode's solution containing 135 mM NaCl , 5.4 mM KCl, 1.8 mM CaCl2, 1.0 mM MgCl2, 0.33 mM NaH2PO4, 10 mM HEPES, and 20 mM glucose (pH was 7.4 with NaOH). The procedures are the same as we reported previously (Imai et al., 2001). After collagenase and protease disrupted the extracellular matrix, the enzymes were washed out by perfusion with 50 ml of recovery solution containing 130 mM potassium aspartate, 5 mM K2ATP, 5 mM HEPES, and 20 mM glucose; pH was adjusted to 7.4 with KOH. The ventricles were removed, and the cells were dispersed in recovery solution and kept at 4°C for at least 1 h. A cell suspension droplet was placed in a chamber (500-µl volume) on the stage of an inverted microscope. After 10 min, superfusion began with Tyrode's solution (2 ml/min) containing 10 mM glucose and 10 mM CsCl (35°C).

Electrophysiology. The patch rupture-whole cell voltage clamp technique used an EPC 7 patch-clamp amplifier (List Electronics, Darmstadt, Germany). Voltage commands and data acquisition were obtained with pClamp software (version 5.5; Axon Instruments, Union City, CA) and a Labmaster TL-1 interface (Axon Instruments). The pipette filling solution for glass electrodes (i.d.,1.1 mm; o.d.,1.3 mm) contained 135 to 140 mM cesium aspartate, 7 mM NaCl, 3.0 mM MgCl2, 3.5 or 5 mM ATPgamma S, 10 mM EGTA, and 10 mM HEPES; pH 7.3 (with CsOH). In some experiments, the pipette solution also contained 1 mM GTP. The electrode resistance was 1 to 3 MOmega . Series resistance could be compensated up to 70% to values between 1 and 2.5 MOmega .

Membrane voltage was stepped from -80 to -40 mV for 300 ms to inactivate the fast Na+ and T-type Ca2+ currents. A second voltage step to +10 mV for 300 ms elicited ICa(L). The clamp protocol was repeated every 10 s.

Drugs and Application. Drugs were applied to myocytes by superfusion by gravity from a reservoir. The applied solutions were warmed to provide an experimental temperature of 35°C. CCh, ISO, 8-Br-cGMP, and 3-isobutyl-1-methylxanthine (IBMX) were prepared fresh daily from aqueous stock solutions.

Data Analysis. With Cs+-rich pipette solution to block membrane K+ currents, ICa(L) is taken as peak current minus end-of-pulse current at +10 mV. Measurements are reported as mean ± S.E.M. The statistical significance of mean differences was determined by Student's t test. p <=  0.05 was considered statistically significant.

    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

8-Br-cGMP inhibits ICa(L) augmented by ISO or IBMX. At 0.1 mM, 8-Br-cGMP inhibited ICa(L) in 0.1 mM IBMX by 34 ± 3.6% and in 10 nM ISO by 32 ± 7.1% (Imai et al., 2001). Accordingly, one would expect 0.1 mM 8-Br-cGMP to suppress cAMP-stimulated ICa(L) by about one-third. In the following experiments, a 10-fold greater concentration of 1 mM 8-Br-cGMP was used.

The results of a test with 8-Br-cGMP on IBMX-stimulated ICa(L) are shown in Fig. 1. The L-channel current was -0.7 nA upon patch rupture and gradually increased to -1.4 nA after 25 min, during which time the cell had been dialyzed with [ATPgamma S]pip of 5 mM. In this experiment, the pipette solution also contained 1 mM GTP. Addition of 0.1 mM IBMX to the superfusion fluid markedly increased ICa(L) to -4.6 nA at 30 min. When 1 mM 8-Br-cGMP was present for 5 min with IBMX, ICa(L) remained at -4.6 nA. Washout of 8-Br-cGMP ensued and ICa(L) remained elevated at -4.6 nA up to 40 min. This result is characteristic of that observed in a total of 21 cells in which 8-Br-cGMP was tested on cAMP-elevated ICa(L). In three of these cells, 10 nM ISO was used to stimulate ICa(L), and the results are included with those obtained with IBMX because the outcome was the same. Overall, the initial ICa(L) just before addition of cAMP-elevating agent was -1.0 ± 0.13 nA and it increased to -2.6 ± 0.27 nA (n = 21). On average, 1 mM 8-Br-cGMP changed cAMP-elevated ICa(L) by -3 ± 11.8% (n = 21), which is not significantly different from 0. 8-Br-cGMP reduced ICa(L) by -16 ± 5.6% (n = 8) in cells dialyzed with ATPgamma S for <25 min, and by 5 ± 18.7% (n = 13) in cells dialyzed for >25 min (p = 0.2). Importantly, if 8-Br-cGMP reduced IBMX-stimulated ICa(L), the effect was transient.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 1.   8-Br-cGMP fails to inhibit IBMX-stimulated ICa(L) in a ventricular myocyte dialyzed with 5 mM ATPgamma S. The pipette solution also had 1 mM GTP. Ordinate, ICa(L) in nanoamperes; abscissa, time in minutes. ICa(L) was 0.7 nA at patch rupture and slowly increased to ~1.4 nA at 25 min. IBMX (0.1 mM), added at 25 min, caused ICa(L) to increase rapidly to 4.6 nA at 30 min. Subsequent addition of 1 mM 8-Br-cGMP negligibly affected IBMX-stimulated ICa(L). Horizontal lines indicate the time and duration of drug additions. Individual current traces recorded at A to E are shown above with current calibration in the right margin.

There were two cells in which we did not observe this pattern; an example is shown in Fig. 2. The L-channel current increased from -1.4 to -2.8 nA during the first 10 min of dialysis; the pipette solution was the same as for the cell in Fig. 1. Addition of 0.1 mM IBMX at 10 min had a small stimulant effect on ICa(L) that eventually reached -3 nA at 16 min. When 1 mM 8-Br-cGMP was added, ICa(L) diminished rapidly over the next 4 min to -0.4 nA. The current did not change appreciably over the ensuing 15 min when 8-Br-cGMP and then IBMX were washed out. This result resembles that reported by Méry et al. (1991) in which cGMP irreversibly reduced cAMP-stimulated ICa(L). However, it is exceptional because it occurred in only 2 of the 23 cells tested and cannot be distinguished from rundown. In both instances, IBMX had been added at about 10 min after patch rupture and 8-Br-cGMP tested 5 min later. The time of IBMX addition ranged from 6 to 28 min with an average of 16 ± 2 min in the 21 cells where the effect of 8-Br-cGMP was suppressed.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2.   An example of an exceptional result when IBMX-stimulated ICa(L) is "irreversibly" reduced by 8-Br-cGMP. Ordinates and abscissa are as in Fig. 1. L-channel current increased from -1.4 nA at patch rupture to -2.7 nA at 10 min. IBMX (0.1 mM) increased ICa(L) to -3 nA by 16 min, and 8-Br-cGMP (1 mM) promptly reduced current to -0.4 nA, which is below the level seen at patch rupture. Washout of 8-Br-cGMP at 21 min with IBMX still present did not cause any further change of ICa(L). See text for details.

Inhibition of ISO- or IBMX-stimulated ICa(L) by CCh has been reported by many investigators. We found that 0.1 mM CCh inhibited ISO-stimulated ICa(L) by 77 ± 7.9% and IBMX-stimulated ICa(L) by 79 ± 6.3% (Imai et al., 2001). However, in cells dialyzed with ATPgamma S, CCh had little effect when tested against IBMX-stimulated ICa(L). An example is shown in Fig. 3. In this cell, ICa(L) was -0.2 nA upon patch rupture and increased to -0.9 nA during the next 20 min as the cell was dialyzed with [ATPgamma S]pip of 5 mM and [GTP]pip of 1 mM. Again, 0.1 mM IBMX, added at 20 min, promptly increased ICa(L) to -5 nA (Fig. 3). Current did not change upon addition of 0.1 mM CCh to the bath fluid for 5 min. When CCh was removed from the IBMX-containing solution, ICa(L) remained at -5 nA through 40 min.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   Dialysis with [ATPgamma S]pip of 5 mM prevents inhibition by CCh of IBMX-stimulated ICa(L). The pipette solution also contained 1 mM GTP. Ordinates and abscissa as in Fig. 1. At patch rupture, ICa(L) was -0.2 nA, and it rose to -0.9 nA after 20 min of dialysis. Addition of 0.1 mM IBMX at 20 min caused ICa(L) to increase rapidly and to reach -4.8 nA at 25 min. Carbachol (0.1 mM) added on top of IBMX during min 26 to 32 did not change ICa(L), which remained elevated after CCh washout.

Overall, 0.1 mM CCh reduced cAMP-elevated ICa(L) by -32 ± 9.9% (n = 12). Although this is substantially less than that observed with ATP in the pipette solution (see above), it is greater than the inhibition observed with 8-Br-cGMP in separate experiments. However, when both were tested in the same six cells against IBMX-stimulated ICa(L), CCh reduced current by -29 ± 13.3% (32 ± 5.2 min) and 8-Br-cGMP reduced it by -21 ± 9.7% (26 ± 7.1 min). In nine cells, we obtained stable recordings during dialysis with [ATPgamma S]pip of 3.5 to 5 mM for >= 45 min. Under these conditions, tests with 1 mM 8-Br-cGMP (n = 5) or with 0.1 mM CCh (n = 7) revealed no inhibition of stimulated ICa(L) by either ligand (data not shown).

    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

With PDEs inactivated by IBMX, we assume that there are two pathways for inhibition of ICa(L) by cGMP/PKG, namely, phosphorylation of the alpha 1c subunit that antagonizes the stimulant effect of cAMP/PKA and/or activation of PP that dephosphorylates the alpha 1c subunit. Can 8-Br-cGMP or CCh suppress Ca2+ current through L-type channels in the presence of ATPgamma S, which allows kinases to thiophosphorylate substrates that resist phosphatase action? Irreversible suppression by 8-Br-cGMP would indicate that thiophosphorylation of the channel had occurred at a site different from that acted upon by cAMP/PKA (Méry et al., 1991; Sumii and Sperelakis, 1995). Alternatively, failure of 8-Br-cGMP to suppress ICa(L) in ATPgamma S would indicate that the thiophosphorylated channel was resistant to phosphatase. Our results are consistent with the PP hypothesis for inhibition by cGMP of current through L-type channels in guinea pig ventricular myocytes.

Neurotransmitter regulation of ICa(L) by reversible phosphorylation-dephosphorylation reactions is well known (McDonald et al., 1994; Herzig and Neumann, 2000). Serine 1928 of the alpha 1c subunit has been reported to be an essential residue for phosphorylation by PKA (Gao et al., 1997). Our results point to the possibility that the site for phosphatase action on the alpha 1c subunit is the same. This conclusion differs from that of others in several ways. Those who report that cGMP irreversibly inhibits ICa(L) by phosphorylation of the channel did experiments in rat ventricular myocytes (Méry et al., 1991; Sumii and Sperelakis, 1995). A similar conclusion emerged from experiments with mouse ventricular myocytes (Klein et al., 2000). We did not observe suppression of basal ICa(L) by 8-Br-cGMP unlike the results from rat ventricular myocytes (Sumii and Sperelakis, 1995). Our experiments and those reporting cGMP/PKG-induced activation of PP are from guinea pig ventricular myocytes (reviewed in Herzig and Neumann, 2000). Different species have distinct regulatory mechanisms for cGMP-dependent regulation of ICa(L). In amphibian ventricular myocytes, cGMP stimulated PDE, which reduces cAMP concentration (reviewed in Méry et al., 1997). This pathway is not prominent in mammalian ventricular myocytes and would be inoperative in our experiments because IBMX inhibits all PDEs. In human atrial trabeculae, 8-Br-cGMP had a negative inotropic effect (Nawrath et al., 1995; Flesch et al., 1997) but increased ICa(L) in single myocytes (Vandecasteele et al., 2001). Stimulation of ICa(L) by 8-Br-cGMP was attributed to activation of PKA. Although PKG was excluded as an effector of 8-Br-cGMP in single atrial myocytes (Vandecasteele et al., 2001), it may have been the target in experiments with human atrial trabecular contractions (Nawrath et al., 1995; Flesch et al., 1997). No information is available on effectors of 8-Br-cGMP in human ventricle, which conceivably differ from those in atrium (Vandecasteele et al., 2001).

8-Br-cGMP could sometimes inhibit ICa(L) in cells dialyzed for <= 25 min with ATPgamma S. However, the inhibition was reversible, a finding inconsistent with cGMP/PKG causing irreversible inhibition via thiophosphorylation of the L-type calcium channel in rat ventricular myocytes (Méry et al., 1991). In only 2 of 23 cells, 8-Br-cGMP addition was accompanied by a sustained decrease of ICa(L) (Fig. 2). Although this could be an example of irreversible inhibition, it cannot be distinguished from current rundown. Sufficient time should be allowed for diffusion of ATPgamma S from the pipette solution and for replacing ATP for participation in thiophosphorylation reactions including those at the L-type calcium channel.

That ATPgamma S interfered with inhibition of ICa(L) by 8-Br-cGMP favors the participation of PKG-activated PP in the cGMP signaling pathway. Dialysis with either PP1 or PP2A opposed ISO-stimulated ICa(L), but not basal ICa(L), in guinea pig ventricular myocytes (Hescheler et al., 1987). Okadaic acid inhibits PP1 and PP2A with the latter being more sensitive (Herzig and Neumann, 2000). Okadaic acid (300 nM in pipette solution) prevented inhibition of ICa(L) by 8-Br-cGMP (Sakai et al., 1999). That okadaic acid inhibits membrane bound PP1 and PP2A activities in guinea pig ventricular myocytes (Neumann et al., 1993) indicates that neither enzyme can be excluded from participating in ICa(L) inhibition. Single channel recordings indicated that PP2A and PP1 dephosphorylate the L-type Ca2+ channel at different sites (Ono and Fozzard, 1993; Wiechen et al., 1995). Together with the present results, the data with okadaic acid favor activation of PP as a mechanism for cGMP/PKG signaling (see also White et al., 1993).

ATPgamma S Prevents Inhibition by Carbachol of ICa(L). The ability of CCh to inhibit ICa(L) diminished in cells dialyzed with ATPgamma S. This is in accordance with the evidence that muscarinic agonist inhibits ICa(L) by activating okadaic acid-sensitive PP (Herzig et al., 1995) and that cGMP is the signal molecule for this action (Imai et al., 2001), presumably by phosphorylating PP (Sakai et al., 1999). Similarly, ACh opposed the action of ISO or dibutyryl-cAMP on the inwardly rectifying K+ current by activation of okadaic acid-sensitive PP in guinea pig ventricular myocytes (Koumi et al., 1995).

However, the effect of ATPgamma S on the response to CCh may not be limited to interference with cGMP-stimulated PP activity. Thiophosphorylation of guanine nucleotides occurs when ATPgamma S is present (Otero et al., 1988; Heidbüchel et al., 1990). Dialysis with ATPgamma S allows formation of GTPgamma S from GDP via nucleoside diphosphate kinase, which is present in cardiac membranes (Heidbüchel et al., 1992), and causes a sustained activation of ACh-activated K+ current (IK(ACh)) in the absence of added guanine nucleotides. The effect of 1 mM ATPgamma S is slow in onset but irreversible after about 20 min (Heidbüchel et al., 1990). GTPgamma S formed from ATPgamma S not only activates IK(ACh) irreversibly but also uncouples G-protein-coupled receptors from intracellular effectors (Breitwieser and Szabo, 1985; Hescheler et al., 1986; Shirayama et al., 1993). In atrial cells, a low concentration (0.4 mM) or brief exposure (4 min) to ATPgamma S was associated with a partially reversible effect on IK(ACh) activation (Heidbüchel et al., 1992).

Limitations. An alternative possibility is that cGMP/PKG not only activates PP but also phosphorylates the alpha 1c subunit in guinea pig ventricular myocytes. That is, with ATP present, both reactions occur and contribute to suppression of cAMP/PKA-activated ICa(L). What happens in the presence of ATPgamma S? With PP activity blocked, the most likely mechanism for inhibition is cGMP/PKG-induced thiophosphorylation of serine 533 on the alpha 1c subunit. If this were so, one would have to conclude that these regulatory sites are not equal and that serine 1928 dominates because when thiophosphorylated by cAMP/PKA, thiophosphorylation of serine 533 by cGMP/PKG is unable to cause inhibition.

We assume that activation of PP by cGMP/PKG occurs at the same site on the alpha 1c subunit as phosphorylation by cAMP/PKA, namely, serine 1928. However, cAMP/PKA also phosphorylates the beta 2a subunit of the L-type Ca2+ channel and this is suggested to regulate current through the pore-forming alpha 1c subunit (Bünemann et al., 1999). However, it is not known if this occurs physiologically because the alpha 1c subunit used in the experiments was truncated and lacked serine 1928.

Conceivably, a membrane-delimited pathway could allow GTPgamma S, generated from ATPgamma S, to activate the L-type channel via the alpha  subunit of the stimulatory guanine nucleotide-binding protein, Gs (Yatani et al., 1987). However, this pathway does not involve phosphorylation-dephosphorylation reactions. In summary, we conclude that inhibition of ICa(L) by cGMP/PKG involves activation of PP in guinea pig ventricular myocytes and that dephosphorylation occurs at the site on alpha 1c subunit phosphorylated by cAMP/PKA.

    Footnotes

Accepted for publication January 14, 2002.

Received for publication October 31, 2001.

This work was supported by U.S. Public Health Service Grant HL-13339.

Address correspondence to: Dr. Achilles J. Pappano, Department of Pharmacology, MC-6125, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030. E-mail: pappano{at}nso1.uchc.edu

    Abbreviations

PKA, protein kinase A; ICa(L), L-type calcium current; ATPgamma S, adenosine 5'-O-(3-thiotriphosphate); GTPgamma S, guanosine 5'-O-(3-thiotriphosphate); CCh, carbachol; IBMX, 3-isobutyl-1-methylxanthine; ISO, isoproterenol; PKG, protein kinase G; PP, protein phosphatase; ACh, acetylcholine; PDE, phosphodiesterase; 8-Br-cGMP, 8-bromo-cGMP; KT5823, (9S,10R)-2,3,9,10,11,12-hexahydro-10-methoxy-2,-9-dimethyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-k]pyrrolo[3,4-i][1,6] benzodiazocine-10-carboxylic acid methyl ester.

    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References


0022-3565/02/3012-0501-0506$03.00
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
CirculationHome page
S.-k. Wei, A. M. Ruknudin, M. Shou, J. M. McCurley, S. U. Hanlon, E. Elgin, D. H. Schulze, and M. C.P. Haigney
Muscarinic Modulation of the Sodium-Calcium Exchanger in Heart Failure
Circulation, March 13, 2007; 115(10): 1225 - 1233.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y.-C. Yu, L.-H. Cao, and X.-L. Yang
Modulation by Brain Natriuretic Peptide of GABA Receptors on Rat Retinal ON-Type Bipolar Cells
J. Neurosci., January 11, 2006; 26(2): 696 - 707.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. Su, P. M. Scholz, and H. R. Weiss
Differential Effects of cGMP Produced by Soluble and Particulate Guanylyl Cyclase on Mouse Ventricular Myocytes
Experimental Biology and Medicine, April 1, 2005; 230(4): 242 - 250.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Xiong, G. R. Ferrier, and S. E. Howlett
Diminished Inotropic Response to Amrinone in Ventricular Myocytes from Myopathic Hamsters Is Linked to Depression of High-Gain Ca2+-Induced Ca2+ Release
J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 761 - 773.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. Liu and P. A. Hofmann
Modulation of protein phosphatase 2a by adenosine A1 receptors in cardiomyocytes: role for p38 MAPK
Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H97 - H103.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shen, J.-B.
Right arrow Articles by Pappano, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shen, J.-B.
Right arrow Articles by Pappano, A. J.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition